GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 18 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | -50.0% | 250 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -33.3% | 250 | 0.0% | 0.00% | – |
Q3 2018 | $3,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q2 2018 | $3,000 | +200.0% | 250 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | -50.0% | 250 | 0.0% | 0.00% | – |
Q4 2017 | $2,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q2 2017 | $2,000 | +100.0% | 250 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ibex Investors LLC | 339,000 | $4,034,000 | 2.29% |
Knoll Capital Management, LLC | 210,000 | $2,499,000 | 2.12% |
BVF INC/IL | 1,761,567 | $20,963,000 | 2.05% |
Vivo Capital, LLC | 792,707 | $9,433,000 | 1.22% |
P.A.W. CAPITAL CORP | 95,000 | $1,131,000 | 1.14% |
683 Capital Management, LLC | 1,350,000 | $16,065,000 | 1.09% |
Unterberg Capital LLC | 50,000 | $595,000 | 0.70% |
SABBY MANAGEMENT, LLC | 232,224 | $2,763,000 | 0.43% |
Nantahala Capital Management | 741,108 | $8,819,000 | 0.36% |
DAFNA Capital Management LLC | 50,000 | $595,000 | 0.28% |